EntrezGene:1026
From FANTOM5_SSTAR
| Symbol: | CDKN1A | ||
|---|---|---|---|
| Description: | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ||
| Synonyms: | CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | ||
| Species: | Human (Homo sapiens) | ||
| Xrefs: |
| ||
| Associated motifs: | NA | ||
| Transcripton Factor?: | No |
TSS regions
| Hg19::chr6:36644021..36644043,+ | p9@CDKN1A |
| Hg19::chr6:36644233..36644248,+ | p3@CDKN1A |
| Hg19::chr6:36644267..36644294,+ | p4@CDKN1A |
| Hg19::chr6:36644295..36644305,+ | p13@CDKN1A |
| Hg19::chr6:36646456..36646461,+ | p14@CDKN1A |
| Hg19::chr6:36646476..36646498,+ | p1@CDKN1A |
| Hg19::chr6:36646510..36646519,+ | p2@CDKN1A |
| TSS peak ID | Short_description |
|---|
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
TSS expression
| Sample | p1@CDKN1A | p2@CDKN1A | p3@CDKN1A | p4@CDKN1A |
|---|
- Click each plot point to find sample in table
ENCODE TF ChIP-seq peak enrichment analysis Analyst: Erik Arner <br>Summary: For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><br><br>link to source dataset.<br>data
No analysis results for this cluster
Details<b>Summary:</b>It includes sequences from the international sequence collaboration, Swiss-Prot, and RefSeq. The RefSeq subset of this file is also available as gene2refseq.<br><br>links to source dataset.<br>human <br>mouse
| GeneID: | 1026 |
|---|---|
| LocusTag: | - |
| chromosome: | 6 |
| map location: | 6p21.2 |
| type of gene: | protein-coding |
| Symbol from nomenclature authority: | CDKN1A |
| Full name from nomenclature authority: | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| Nomenclature status: | O |
| Other designations: | CDK-interacting protein 1, CDK-interaction protein 1, DNA synthesis inhibitor, cyclin-dependent kinase inhibitor 1, melanoma differentiation associated protein 6, wild-type p53-activated fragment 1, CDK-interacting protein 1;;CDK-interaction protein 1;;DNA synthesis inhibitor;;cyclin-dependent kinase inhibitor 1;;melanoma differentiation associated protein 6;;wild-type p53-activated fragment 1 |
| Modification date: | 08.01.2012 |
